MARIA CLARA
ALVAREZ VILLAMARIN
Catedrática de universidade
Hospital Miguel Servet
Zaragoza, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Miguel Servet (1)
2018
-
Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476